GlaxoSmithKline denies it has settled thousands of lawsuits over rosiglitazone (Avandia)BMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c3010 (Published 07 June 2010) Cite this as: BMJ 2010;340:c3010
- Janice Hopkins Tanne
- 1New York
GlaxoSmithKline has denied claims that it has settled “thousands” of the lawsuits brought against the company by people who had heart attacks and strokes while taking the anti-diabetic drug rosiglitazone (Avandia).
A company spokeswoman told the BMJ that many settlements, as reported by Reuters (www.reuters.com/article/idUSLDE65029L20100601), which later issued an update, and by other media outlets, did not happen.
The spokeswoman said that there had been “erroneous media reports on the pending litigation,” and the truth was that the company had settled only one case set for trial in Philadelphia on 1 June. Terms of the settlement were not disclosed.
An estimated 13 000 cases are …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial